Show simple item record

dc.contributor.authorMullaney, L.
dc.contributor.authorO'Shea, E.
dc.contributor.authorDunne, M.
dc.contributor.authorFinn, M.
dc.contributor.authorThirion, P.
dc.contributor.authorCleary, L. A.
dc.contributor.authorMcGarry, M.
dc.contributor.authorO'Neill, L.
dc.contributor.authorArmstrong, J.G.
dc.date.accessioned2014-08-15T08:45:30Z
dc.date.available2014-08-15T08:45:30Z
dc.date.issued2014-01-10
dc.identifier.citationMullaney L et al. A randomized trial comparing bladder volume consistency during fractionated prostate radiation therapy. Pract Rad Oncol. Jan 10 2014 [published online]en_GB
dc.identifier.doihttp://dx.doi.org/10.1016/j.prro.2013.11.006
dc.identifier.urihttp://hdl.handle.net/10147/324811
dc.description.abstractOrgan motion is a contributory factor to the variation in location of the prostate and organs at risk during a course of fractionated prostate radiation therapy (RT). A prospective randomized controlled trial was designed with the primary endpoint to provide evidence-based bladder-filling instructions to achieve a consistent bladder volume (BV) and thus reduce the bladder-related organ motion. The secondary endpoints were to assess the incidence of acute and late genitourinary (GU) and gastrointestinal (GI) toxicity for patients and patients’ satisfaction with the bladder-filling instructions.
dc.language.isoenen
dc.subjectPROSTATE CANCERen_GB
dc.subject.otherRADIATION THERAPYen_GB
dc.titleA randomized trial comparing bladder volume consistency during fractionated prostate radiation therapyen_GB
dc.typeArticleen
dc.identifier.journalPractical Radiation Oncologyen_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
html.description.abstractOrgan motion is a contributory factor to the variation in location of the prostate and organs at risk during a course of fractionated prostate radiation therapy (RT). A prospective randomized controlled trial was designed with the primary endpoint to provide evidence-based bladder-filling instructions to achieve a consistent bladder volume (BV) and thus reduce the bladder-related organ motion. The secondary endpoints were to assess the incidence of acute and late genitourinary (GU) and gastrointestinal (GI) toxicity for patients and patients’ satisfaction with the bladder-filling instructions.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record